Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

Share Price is delayed by 15 minutes
Get Live Data
5.625    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.25 (4.545%)
Market Cap: £5.00m
CRU Live PriceLast checked at - London Stock Exchange

Intraday Coral Products Share Chart

Trading Statement

8 Jun 2017 07:00

RNS Number : 4814H
Coral Products PLC
08 June 2017
 

Coral Products plc

Trading update

Further to the Company's trading update dated 27 January 2017, the Board is pleased to announce that the immediate actions taken by management in Q3 to address poor trading performance at the Company's subsidiary, Coral Products Mouldings Limited in November and December 2016 have resulted in a much improved performance in that subsidiary for the remainder of the financial year ended 30 April 2017. Additional significant orders are expected to further improve performance in the current financial year.

As stated in the January update, all other Group operations remained on budget and trading profitably and this has continued to be the case through to the year end.

Overall, the Board is pleased to report that Group underlying profit for the year (defined as operating profit before share option and intangibles amortisation charges and also compensation for loss of office) is expected to be in line with the Board's and market's revised expectations.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Enquiries:

 

Coral Products plc

Tel: 07703 518 148

Joe Grimmond, Chairman

 

 

 

 

 

Cairn Financial Advisers LLP

Tel: 020 7213 0880

Nominated Adviser

 

Tony Rawlinson / Liam Murray

 

 

 

Daniel Stewart & Company plc

Tel: 020 7776 6550

Broker

 

David Lawman

 

 

 

Capital Markets Consultants Limited

Tel: 07515 587 184

PR

 

Richard Pearson

 

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBDLLBDQFEBBD
Date   Source Headline
20th Apr 20264:15 pmRNSDirector/PDMR Shareholding
20th Apr 202612:20 pmRNSTrading Update
16th Feb 20267:00 amRNSAcquisition of the assets of AAC Cyroma Limited
8th Jan 20267:00 amRNSHalf-year Financial Report
26th Nov 20254:45 pmRNSResult of AGM & Directorate Change
26th Nov 20257:00 amRNSAGM Statement
31st Oct 202512:00 pmRNSNotice of AGM and Posting of Annual Report
31st Oct 20257:00 amRNSFinal Results
28th Aug 20253:50 pmRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
10th Jul 20258:58 amRNSDirectorate Change
8th Jul 202510:08 amRNSIssue of Options
7th Jul 202510:08 amRNSFull Year Trading Update and Acquisition Update
30th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirectorate Change
4th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20252:15 pmRNSDirector/PDMR Shareholding
1st Apr 20253:50 pmRNSAcquisition of the assets of Arrow Film Converters
20th Mar 202511:00 amRNSIce Cream & Food Container three-year Agreement
4th Mar 20257:00 amRNSRenewal of Contract
27th Feb 202512:57 pmRNSDirector/PDMR Shareholding
26th Feb 202511:07 amRNSDirector/PDMR Shareholding
21st Feb 202511:02 amRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSCompletion of Property Sale and Directorate Change
3rd Feb 20257:00 amRNSChange of Adviser
28th Jan 20254:35 pmRNSDirector/PDMR Shareholding
27th Jan 20257:00 amRNSHalf-year Report
7th Jan 20257:00 amRNSProperty Sales and Insurance Claim Settlement
4th Dec 20247:00 amRNSDirectorate Change
12th Nov 20247:00 amRNSDirectorate Change
25th Oct 20247:00 amRNSDirectorate Change
23rd Oct 20244:30 pmRNSResult of General Meeting
14th Oct 20247:00 amRNSTrading Statement
17th Sep 20247:00 amRNSFinal Results
24th Jul 20247:00 amRNSSale and Leaseback of Runcorn Factory Site
11th Jun 20247:00 amRNSTrading Statement
23rd May 20245:45 pmRNSTransaction in Own Shares
23rd May 20247:00 amRNSDirector/PDMR Shareholding
22nd May 20246:20 pmRNSTransaction in Own Shares
13th May 20244:30 pmRNSDirector/PDMR Shareholding
9th May 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSTrading Statement
11th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSTrading Update and Directorate Change
7th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Oct 20235:21 pmRNSTransaction in Own Shares
12th Oct 20235:22 pmRNSTransaction in Own Shares
11th Oct 20235:52 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.